AvenCell Therapeutics Inc is a clinical-stage cell therapy company specializing in the development of both autologous and allogeneic switchable CAR-T cell therapies. The company is focused on utilizing its proprietary Universal Switchable CAR-T cell therapy platform to treat a wide range of hematologic malignancies and autoimmune diseases.
Leadership & Board
Current Number of Employees63
Current LinkedIn Followers4,390
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$112M
Total Amount Raised$112M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$112M
Latest Funding Amount$112M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
AvenCell Therapeutics Inc had 63 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
63Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
AvenCell Therapeutics Inc had 4,390 followers as of October 5, 2026. The number of followers increased by 15 (0.34%) week-over-week.
4,390Latest Followers Count
15(0.34%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.